GAVISCONPRO MENTHE, oral suspension in a sachet 20 sachets of 10 ml
Active ingredients: Sodium alginate, Potassium hydrogen carbonate
Commercialized according to BDPM
Oral suspension20 sachets of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAVISCONPRO MENTHE, suspension buvable en sachet
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 20 sachet(s) aluminium polyéthylène polyester de 10 ml
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Sept 2019
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63830290CIP73006300CIP133400930063002Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BICARBONATE DE POTASSIUMsuspension | 200 mg · un sachet de 10ml | SA |
| ALGINATE DE SODIUMsuspension | 1000 mg · un sachet de 10ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.